DCGO · DocGo Inc. · Investor Relations
$0.18
+0.00 (+2.05%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— cleared Nov 9, 2026
The latest filing states the doubt was alleviated.
“While these plans carry meaningful inherent risk to operations, the Company’s management and the Board of Directors have evaluated these conditions in totality and conclude it is probable that, when implemented, the plans will be sufficient to alleviate substantial doubt about the Company’s ability to continue as a going concern for the next twelve months.”View the 10-Q filed Nov 9, 2026
Market Cap
$17.37M
Shares
98.99M
Volume · Nov 18
555.8K
Avg daily vol (3M)
773.15K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-11-09 | DocGo Announces Third Quarter 2026 Results and CEO Transition |
| 2026-11-03 | DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026 |
| 2026-08-17 | DocGo Announces Second Quarter 2026 Results |
| 2026-05-11 | DocGo Announces First Quarter 2026 Results |
| 2026-03-16 | DocGo Announces Fourth Quarter and Full Year 2025 Results |
| 2025-11-10 | DocGo Announces Third Quarter 2025 Results |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-09 | Q3 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-09-29 | Webinar: DocGo’s Pending Acquisition of Hicuity Health | Webcast |
| 2026-09-16 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-08-17 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-08 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-11 | First Quarter 2026 Earnings Call | Earnings call |
| 2026-03-16 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.docgo.com/
Key facts
CIK
1822359
CUSIP
256086109
13F (30d)
95 filings
82 filers
Visit website
Investor relations